{"i": ["Topical clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["corticosteroids"], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol"], "o": []}
{"i": [], "o": []}
{"i": ["placebo - controlled", "clobetasol"], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol 0 . 05 % ointment or control petrolatum ointment"], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol", "clobetasol"], "o": ["time to cessation of skin detachment"]}
{"i": [], "o": ["time to 90 % re - epithelialization and percentage of affected skin", "efficacy"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["corticosteroids"], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol"], "o": []}
{"i": [], "o": []}
{"i": ["placebo - controlled", "clobetasol"], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol 0 . 05 % ointment or control petrolatum ointment"], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol", "clobetasol"], "o": ["time to cessation of skin detachment"]}
{"i": [], "o": ["time to 90 % re - epithelialization and percentage of affected skin", "efficacy"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["allopurinol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Mortality"]}
{"i": [], "o": ["permanent vision loss and adhesions of the genitalia"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["inhibitors of TNF including infliximab and etanercept", "systemic corticosteroids , intravenous immunoglobulin therapy , plasmapheresis , cyclosporine"], "o": []}
{"i": ["thalidomide"], "o": []}
{"i": ["systemic corticosteroids"], "o": []}
{"i": ["systemic corticosteroids", "supportive care"], "o": ["complications and mortality rate"]}
{"i": [], "o": ["sepsis and delayed re - epithelialization"]}
{"i": ["glucocorticoids"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["corneal ulceration , episcleritis"]}
{"i": ["Corticosteroids"], "o": ["ocular cicatrization and vision loss"]}
{"i": [], "o": []}
{"i": [], "o": ["adverse events"]}
{"i": ["topical clobetasol"], "o": ["safety and clinical outcomes"]}
{"i": ["placebo - controlled", "clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["topical clobetasol 0 . 05 % ointment (' treatment ') or inert petrolatum ointment (' placebo ')"], "o": []}
{"i": ["placebo"], "o": []}
{"i": ["clobetasol", "placebo"], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol and placebo -"], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["skin detachment"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol 0 . 05 % ointment or control petrolatum ointment"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol ointment"], "o": []}
{"i": ["clobetasol ointment"], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol", "Clobetasol"], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": ["clobetasol or petrolatum ointments"], "o": []}
{"i": ["antibacterial xeroform dressings and sterile gauze ."], "o": []}
{"i": ["occlusive dressings , antibacterial ointments , or skin xenografts ."], "o": []}
{"i": [], "o": []}
{"i": ["xenograft", "topical antibacterial ointment"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["numeric cellulitis score"]}
{"i": [], "o": []}
{"i": [], "o": ["Nikolsky sign", "time to cessation of skin detachment"]}
{"i": [], "o": ["time to 90 % re - epithelialization , percentage affected body surface area , and percentage surface area of detached skin ."]}
{"i": [], "o": []}
{"i": ["TEN"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["RLT - plus buffer ( Qiagen ) with 1 % mercaptoethanol and Qiazol ( Qiagen )"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Gene expression levels"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol"], "o": ["systemic infections", "rate of infection"]}
{"i": [], "o": []}
{"i": ["clobetasol"], "o": ["skin healing", "disease duration"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["total cellulitis score"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol"], "o": ["risk of systemic infection ( sepsis"]}
{"i": [], "o": ["serious adverse events"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol", "placebo -"], "o": ["days to cessation of skin detachment"]}
{"i": [], "o": ["number of days"]}
{"i": [], "o": []}
{"i": [], "o": ["days to cessation of skin detachment"]}
{"i": [], "o": []}
{"i": [], "o": ["number of days to cessation of skin detachment"]}
{"i": [], "o": []}
{"i": ["clobetasol", "placebo -"], "o": []}
{"i": [], "o": ["time to 90 % re - epithelialization , time to cessation of skin detachment , percentage affected surface area , and percentage surface area of detached skin )"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["Topical steroids"], "o": []}
{"i": ["topical steroids"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["corticosteroid therapy", "Topical steroids"], "o": ["systemic side effects"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["topical steroids"], "o": ["visual outcomes", "disease duration"]}
{"i": ["topical ocular steroids"], "o": ["visual outcomes"]}
{"i": ["topical steroids"], "o": ["20 / 200 vision or better"]}
{"i": [], "o": ["percentage of patients with 20 / 20 vision or better"]}
{"i": [], "o": ["worse than 20 / 2 , 000 vision"]}
{"i": [], "o": []}
{"i": [], "o": ["survival"]}
{"i": ["corticosteroids"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["supportive care , systemic corticosteroids , and systemic corticosteroids plus intravenous immunoglobulin therapy", "corticosteroids", "steroids", "intravenous immunoglobulin therapy"], "o": ["survival benefit"]}
{"i": ["systemic corticosteroid"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["systemic absorption and adverse effects"]}
{"i": ["steroids"], "o": []}
{"i": ["topical calcipotriene plus betamethasone diproprionate"], "o": ["adrenal suppressive effects", "adrenal suppression"]}
{"i": [], "o": ["local or systemic infection"]}
{"i": ["topical clobetasol"], "o": ["infection risk", "cutaneous infection", "cellulitis"]}
{"i": [], "o": ["infection risk"]}
{"i": [], "o": ["infectious complications", "prevalence of diabetes"]}
{"i": [], "o": ["necrotizing fasciitis"]}
{"i": ["topical steroid treatment"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["skin appearance"]}
{"i": [], "o": ["concentration delivered to the skin"]}
{"i": [], "o": []}
{"i": ["placebo -"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["time to complete re - epithelialization"]}
{"i": [], "o": ["complete re - epithelialization", "time to 90 % re - epithelialization"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["emollients", "topical steroids", "steroids"], "o": []}
{"i": ["topical steroids"], "o": ["safety and efficacy"]}
{"i": [], "o": ["ocular disease duration , severity , and long - term visual sequelae"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["clobetasol"], "o": []}
{"i": [], "o": ["pro - apoptotic genes"]}
{"i": ["topical steroids"], "o": ["safety and efficacy"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
